It may seem like an unlikely connection, but an aversion to kitty litter has led to a very interesting discovery about post-traumatic stress disorder (PTSD) that could one day lead to a diagnostic test and perhaps even a drug therapy,

GE Healthcare and NorthStar Medical RadioIsotopes have signed a letter of intent for the production and distribution of an American supply of medical isotopes, including the largest staple isotope, molybdenum-99 (Mo-99), NorthStar announced today.

A bioluminescence technique is being developed to monitor an adenovirus-mediated cancer gene therapy by following signs of apoptosis, or cell death, according to a study published online Aug. 13 in the journal Molecular Imaging.

The University of Texas MD Anderson Cancer Center is opening a full-service diagnostic imaging center in west Houston, it announced.

The ASRT Foundation and Siemens Healthcare USA are excited to announce the recipients of the 2014 Siemens Clinical Advancement Scholarship.

Amyloid imaging has held center stage in research into the process of Alzheimer’s disease (AD), but studies presented at last month’s Alzheimer's Association International Conference revealed how far tau imaging has come as well as new insights into yet another protein implicated in AD.

A New York Times piece reviews recent research on the safety of potential Alzheimer’s therapies that focus on genetic factors of the disease. APOE is a hallmark risk factor and perhaps the most common in those who progress to Alzheimer’s, and often earlier than others.

A powerhouse of genomic information has led to a revamped tumor classification system that reclassifies as many as one out of every 10 cancer cases, according to a meta-analysis published Aug. 7 in the journal Cell.